Skip to main content
. 2022 Jul 22;12:846819. doi: 10.3389/fcimb.2022.846819

Table 4.

Overview of the efficacy of antimicrobial agents towards the collected V. cholerae, V. parahaemolyticus, and V. vulnificus isolates.

Antimicrobial agent a V. cholerae non-O1/non-O139 n = 34 V. parahaemolyticus n = 198 V. vulnificus n = 102
S (%) I (%) R (%) S (%) I (%) R (%) S (%) I (%) R (%)
Ampicilin and Sulbactam 100 0 0 100 0 0 99 0 1
Ampicillin 91 0 9 5 5 90 94 0 6
Aztreonam 100 0 0 99 1 0 97 3 0
Cefazolin 15 32 53 2 31 67 97 2 1
Cefepime 100 0 0 99 1 0 92 8 0
Ceftazidim 100 0 0 99 1 0 99 1 0
Cefuroxim 100 0 0 79 19 2 97 2 1
Ciproflaxacin 100 0 0 100 0 0 99 1 0
Meropenem 91 9 0 99 1 0 98 2 0
Oxacillin 0 0 100 0 0 100 0 0 100
Penicillin 0 0 100 0 0 100 0 0 100
Trimethoprim-sulfamethoxazole 9 0 91 46 14 40 66 15 19

S, susceptible; I, intermediate resistant; R, resistant.

a

All non-O1/non-O139 V. cholerae, V. parahaemolyticus, and V. vulnificus isolates were susceptible to doxycycline, levofloxacin, norfloxacin, and tetracycline.